drugset / Trial / NCT01299753

Catecholamine Blockade Post-burn

NCT01299753

Unknown 80 enrolled Sunnybrook Health Sciences Centre
RandomizedParallel-groupSingle-blindTreatment

Summary

Severe burn is associated with a wide array of stress, metabolic, and physiologic processes in an attempt to restore homeostasis. The catecholamine induced stress response following severe burns is particularly exaggerated and manifests detrimentally as inflammation, insulin resistance, hypermetabolism, and associated profound protein catabolism. The investigators hypothesize that catecholamine blockade will lead to restored IR signaling and result in improved post-burn morbidity. The investigators will further determine the molecular mechanisms mediating these effects.

Timeline

Start
2011-02
Primary completion
2022-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 20 mg
Subject Propranolol Small molecule 40 mg

Indications

No indication recorded.